| Patient | Sonny Liston |
|---|---|
| Date of birth | 1932-05-08 |
| Identifiers | MRN HR-BX007-SYN-TD; SSN (made up) 000-07-8853 |
| Document date | 2026-11-01 |
| Author | Malcolm Achebe-Whitford, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Establishing care: a high blood pressure reading at a boxing commission check, trauma-informed history, alcohol and drug screening with a safety assessment, and health literacy. Concerns: He wants to keep fighting and needs his blood pressure under control to pass the commission physical; He wants things explained to him out loud, not handed to him on paper; He knows he drinks too much between fights and wants to cut down without being lectured. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 5 mg and valsartan 160 mg combined oral tablet, one tablet each morning | One tablet each morning | Oral route | 1969-06-23 to 1969-07-21 | completed | S |
| Amlodipine 10 mg and valsartan 160 mg combined oral tablet, one tablet each morning | One tablet each morning | Oral route | 1969-07-21 | active | S |
| Naltrexone 50 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 1969-07-21 | active | S |
| Pseudoephedrine 30 mg oral tablet, bought over the counter as a cold tablet, two tablets up to four times a day | Two tablets up to four times a day | Oral route | 1969-09-05 to 1969-09-08 | stopped | S |
| Acetaminophen 500 mg oral tablet, one or two tablets every six hours as needed for aches, no more than four tablets (2 g) a day because he drinks | One or two tablets every six hours as needed; no more than four tablets a day | Oral route | 1969-09-08 to 1969-09-15 | completed | S |
| Saline nasal spray 0.65%, two sprays in each nostril as needed | Two sprays in each nostril as needed | Nasal route | 1969-09-08 to 1969-09-15 | completed | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Twelve-lead ECG: sinus bradycardia at 56 per minute; voltage criteria for left ventricular hypertrophy without repolarization changes; normal intervals (PR 168 ms, QRS 96 ms, QTc 402 ms) | 1969-06-09 to 1969-06-09 | completed | S |
| 24-hour ambulatory blood pressure monitoring: daytime average 146/94 mmHg, nighttime average 132/84 mmHg, 24-hour average 142/91 mmHg; nighttime fall 10 percent; confirms hypertension | 1969-06-17 to 1969-06-18 | completed | S |
| Transthoracic echocardiogram: mild concentric left ventricular hypertrophy (septum and posterior wall 12 mm), normal chamber size, ejection fraction 60 percent, normal diastolic function (septal e' 10 cm/s), normal valves, aortic root 34 mm | 1969-06-23 to 1969-06-23 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1969-08-11 | Tdap vaccine; no record of an earlier tetanus booster | completed | S |
| 1969-08-11 | Hepatitis B vaccine (HepB-CpG), dose 1 of 2, recommended for all adults 19 to 59 | completed | S |
| 1969-09-22 | Hepatitis B vaccine (HepB-CpG), dose 2 of 2 | completed | S |
| 1969-10-20 | Influenza vaccine, 1969-1970 season | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| Childhood | Physical abuse in childhood (beaten regularly by his father) and full-time field work from the age of eight | D (CLM-0002) |
| 1954 | Broken jaw in a professional bout in 1954 | D (CLM-0005) |
| February 25, 1964 | Shoulder injury cited when he did not come out for the seventh round of a title fight in 1964 | D (CLM-0005) |
| September 1953 | Professional boxing since 1953, about 50 bouts as a heavyweight, still active | D (CLM-0005) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| He wants to keep fighting and needs his blood pressure under control to pass the commission physical | active | S |
| He wants things explained to him out loud, not handed to him on paper | active | S |
| He knows he drinks too much between fights and wants to cut down without being lectured | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 15.1 on 1969-06-09; MCV [Entitic mean volume] in Red Blood Cells by Automated count 98 on 1969-06-09; Sodium [Moles/volume] in Serum or Plasma 139 on 1969-06-09; Potassium [Moles/volume] in Serum or Plasma 4.4 on 1969-07-21; Creatinine [Mass/volume] in Serum or Plasma 1.1 on 1969-07-21; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1964)/1.73 sq M 89 on 1969-07-21; Glucose [Mass/volume] in Serum or Plasma 92 on 1969-06-09; Calcium [Mass/volume] in Serum or Plasma 9.6 on 1969-06-09; Hemoglobin A1c/Hemoglobin.total in Blood 5.4 on 1969-06-09; Cholesterol [Mass/volume] in Serum or Plasma 204 on 1969-06-09; Cholesterol in HDL [Mass/volume] in Serum or Plasma 58 on 1969-06-09; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 122 on 1969-06-09; Triglyceride [Mass/volume] in Serum or Plasma 120 on 1969-06-09; Albumin/Creatinine [Mass Ratio] in Urine 18 on 1969-06-09; Thyrotropin [Units/volume] in Serum or Plasma 1.6 on 1969-06-09; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 on 1969-09-22; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30 on 1969-09-22; Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 41 on 1969-10-20; Total score [AUDIT] 7 on 1969-10-20; Total score [DAST-10] 0 on 1969-06-09; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 on 1969-10-20; PC-PTSD-5 score [PC-PTSD-5] 1 on 1969-06-09; Total score [AUDIT-C] 4 on 1969-09-22; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1969-08-11 [S]
Strengths and supports: Strengths and supports: discipline and daily training, physical strength, a sharp memory, his family, his trainer and gym, and the steadiness he says boxing gave him [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| High blood pressure readings at a first visit (154/98 mmHg, average of two readings with a large cuff), without a diagnosis of hypertension; out-of-office confirmation needed | resolved | confirmed | R03.0 | S — Synthetic presenting finding; resolved into the diagnosis at the consultation visit when ambulatory monitoring confirmed hypertension. |
| Hypertension, stage 2, confirmed by 24-hour ambulatory monitoring (daytime average 146/94 mmHg, nighttime 132/84 mmHg), with mild concentric left ventricular hypertrophy on echocardiography and normal kidney function and urine albumin | active | confirmed | I10 | S — Synthetic modern diagnosis; no hypertension is documented in his life. |
| Alcohol use disorder, moderate (four DSM-5-TR criteria: drinking more than intended, unsuccessful efforts to cut down, craving, and continued drinking despite its effect on his training, blood pressure and liver tests); AUDIT 16 | active | confirmed | F10.20 | S — Synthetic modern diagnosis by interview, anchored to the description of heavy drinking; not a historical diagnosis. |
| Personal history of physical abuse in childhood (beaten regularly by his father), with heavy field work from the age of eight | active | confirmed | Z62.810 | S — Synthetic coding of the documented childhood history; physical abuse only. |
| Does not read or write (no schooling as a child); prefers spoken explanations, pictures and demonstrations | active | confirmed | Z55.0 | S — Synthetic coding of the documented literacy, recorded so that care is adapted. |
| Acute viral upper respiratory infection (common cold) for four days, with blood pressure raised to 158/98 mmHg by an over-the-counter pseudoephedrine cold tablet he could not read the label of; resolved | resolved | confirmed | J06.9 | S — Synthetic acute illness; not a historical claim. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1969-06-09 | Hemoglobin [Mass/volume] in Blood | 15.1 | g/dL | 13.5-17.5 g/dL | Normal | S |
| 1969-06-09 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 98 | fL | 80-100 fL | Normal | S |
| 1969-06-09 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1969-06-09 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1969-06-09 | Creatinine [Mass/volume] in Serum or Plasma | 1.1 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1969-06-09 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1964)/1.73 sq M | 89 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1969-06-09 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 1969-06-09 | Calcium [Mass/volume] in Serum or Plasma | 9.6 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1969-06-09 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4 | % | <=5.6% | Normal | S |
| 1969-06-09 | Cholesterol [Mass/volume] in Serum or Plasma | 204 | mg/dL | <=199 mg/dL | High | S |
| 1969-06-09 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 58 | mg/dL | >=40 mg/dL | Normal | S |
| 1969-06-09 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 122 | mg/dL | <=129 mg/dL | Normal | S |
| 1969-06-09 | Triglyceride [Mass/volume] in Serum or Plasma | 120 | mg/dL | <=149 mg/dL | Normal | S |
| 1969-06-09 | Albumin/Creatinine [Mass Ratio] in Urine | 18 | mg/g | <=29 mg/g | Normal | S |
| 1969-06-09 | Thyrotropin [Units/volume] in Serum or Plasma | 1.6 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 1969-06-09 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 46 | U/L | 10-40 U/L | High | S |
| 1969-06-09 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 38 | U/L | 7-56 U/L | Normal | S |
| 1969-06-09 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 88 | U/L | 8-61 U/L | High | S |
| 1969-06-09 | Total score [AUDIT] | 16 | {score} | S | ||
| 1969-06-09 | Total score [DAST-10] | 0 | {score} | S | ||
| 1969-06-09 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S | ||
| 1969-06-09 | PC-PTSD-5 score [PC-PTSD-5] | 1 | {score} | S | ||
| 1969-07-21 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1969-07-21 | Creatinine [Mass/volume] in Serum or Plasma | 1.1 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1969-07-21 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1964)/1.73 sq M | 89 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1969-07-21 | Total score [AUDIT-C] | 7 | {score} | S | ||
| 1969-09-22 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 31 | U/L | 10-40 U/L | Normal | S |
| 1969-09-22 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 30 | U/L | 7-56 U/L | Normal | S |
| 1969-09-22 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 54 | U/L | 8-61 U/L | Normal | S |
| 1969-09-22 | Total score [AUDIT-C] | 4 | {score} | S | ||
| 1969-10-20 | Total score [AUDIT] | 7 | {score} | S | ||
| 1969-10-20 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 41 | U/L | 8-61 U/L | Normal | S |
| 1969-10-20 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | S | ||
| 1969-08-11 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1969-06-09 | Body height | 185 | cm | S |
| 1969-06-09 | Body weight | 99 | kg | S |
| 1969-06-09 | Body mass index (BMI) [Ratio] | 28.9 | kg/m2 | S |
| 1969-06-09 | Systolic blood pressure | 154 | mm[Hg] | S |
| 1969-06-09 | Diastolic blood pressure | 98 | mm[Hg] | S |
| 1969-06-09 | Heart rate | 58 | /min | S |
| 1969-06-09 | Respiratory rate | 14 | /min | S |
| 1969-06-09 | Body temperature | 36.7 | Cel | S |
| 1969-06-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1969-06-23 | Body height | 185 | cm | S |
| 1969-06-23 | Body weight | 98.6 | kg | S |
| 1969-06-23 | Body mass index (BMI) [Ratio] | 28.8 | kg/m2 | S |
| 1969-06-23 | Systolic blood pressure | 148 | mm[Hg] | S |
| 1969-06-23 | Diastolic blood pressure | 96 | mm[Hg] | S |
| 1969-06-23 | Heart rate | 56 | /min | S |
| 1969-06-23 | Respiratory rate | 14 | /min | S |
| 1969-06-23 | Body temperature | 36.6 | Cel | S |
| 1969-06-23 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1969-07-21 | Body height | 185 | cm | S |
| 1969-07-21 | Body weight | 98 | kg | S |
| 1969-07-21 | Body mass index (BMI) [Ratio] | 28.6 | kg/m2 | S |
| 1969-07-21 | Systolic blood pressure | 136 | mm[Hg] | S |
| 1969-07-21 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 1969-07-21 | Heart rate | 58 | /min | S |
| 1969-07-21 | Respiratory rate | 14 | /min | S |
| 1969-07-21 | Body temperature | 36.6 | Cel | S |
| 1969-07-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1969-09-22 | Body height | 185 | cm | S |
| 1969-09-22 | Body weight | 97.2 | kg | S |
| 1969-09-22 | Body mass index (BMI) [Ratio] | 28.4 | kg/m2 | S |
| 1969-09-22 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1969-09-22 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1969-09-22 | Heart rate | 56 | /min | S |
| 1969-09-22 | Respiratory rate | 14 | /min | S |
| 1969-09-22 | Body temperature | 36.6 | Cel | S |
| 1969-09-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1969-10-20 | Body height | 185 | cm | S |
| 1969-10-20 | Body weight | 97 | kg | S |
| 1969-10-20 | Body mass index (BMI) [Ratio] | 28.3 | kg/m2 | S |
| 1969-10-20 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1969-10-20 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1969-10-20 | Heart rate | 56 | /min | S |
| 1969-10-20 | Respiratory rate | 14 | /min | S |
| 1969-10-20 | Body temperature | 36.5 | Cel | S |
| 1969-10-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1969-08-11 | Body height | 185 | cm | S |
| 1969-08-11 | Body weight | 97.6 | kg | S |
| 1969-08-11 | Body mass index (BMI) [Ratio] | 28.5 | kg/m2 | S |
| 1969-08-11 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1969-08-11 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1969-08-11 | Heart rate | 56 | /min | S |
| 1969-08-11 | Respiratory rate | 14 | /min | S |
| 1969-08-11 | Body temperature | 36.6 | Cel | S |
| 1969-08-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1969-09-08 | Body height | 185 | cm | S |
| 1969-09-08 | Body weight | 97.2 | kg | S |
| 1969-09-08 | Body mass index (BMI) [Ratio] | 28.4 | kg/m2 | S |
| 1969-09-08 | Systolic blood pressure | 158 | mm[Hg] | S |
| 1969-09-08 | Diastolic blood pressure | 98 | mm[Hg] | S |
| 1969-09-08 | Heart rate | 78 | /min | S |
| 1969-09-08 | Respiratory rate | 16 | /min | S |
| 1969-09-08 | Body temperature | 37.6 | Cel | S |
| 1969-09-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1969-06-09 | Establishing care: a high blood pressure reading at a boxing commission check, trauma-informed history, alcohol and drug screening with a safety assessment, and health literacy | finished | S |
| 1969-06-23 | Two-week review, seen the same day by cardiology: ambulatory monitoring, echocardiogram, the diagnosis and treatment, and fitness to compete | finished | S |
| 1969-07-21 | Four-week review: blood pressure on treatment, potassium and creatinine, drinking, and medicine teach-back | finished | S |
| 1969-09-22 | Three-month review: blood pressure, liver tests and drinking on naltrexone | finished | S |
| 1969-10-20 | Four-month review: blood pressure at goal, AUDIT, and the plan ahead | finished | S |
| 1969-08-11 | Periodic adult preventive visit | finished | S |
| 1969-09-08 | Same-day sick visit for a cold and raised blood pressure | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Confirm the blood pressure out of the office with 24-hour ambulatory monitoring before any diagnosis or medicine; baseline metabolic panel, glucose, lipids, urine albumin, TSH and ECG | completed | GL-AHA-HTN-2025, GL-USPSTF-HTN-2021, GL-CMID-2026 | S |
| Cardiology consultation on the same day as the two-week visit: confirm and stage the hypertension, echocardiogram, choice of treatment, and fitness to compete | completed | GL-AHA-HTN-2025, GL-ATHLETE-HTN-2015 | S |
| Alcohol: nonjudgmental brief intervention with motivational interviewing; a drinking goal he sets himself; medicines (naltrexone, acamprosate or topiramate) explained; AUDIT-C at each follow-up and liver tests | completed | GL-NIAAA-CORE, GL-SUD-2021, GL-APA-AUD-2018, GL-USPSTF-ALC-2018 | S |
| Safety plan given out loud and as a picture card, with the 988 Suicide & Crisis Lifeline saved in his phone as a voice contact; safety reviewed at every visit | completed | GL-SUICIDE-2024 | S |
| Health literacy universal precautions at every visit: plain spoken explanations, one or two key points at a time, teach-back, a picture-based medicine and blood pressure card, consent forms read aloud with time for questions, phone and voice-message reminders instead of letters, and an adult literacy program offered without pressure | completed | GL-AHRQ-HL-2024 | S |
| Trauma-informed care: an ACE-informed history in which he chooses what to share, explanation and permission before each part of the examination, a PTSD screen, and counseling offered | completed | GL-SAMHSA-TIP57-2014, GL-PTSD-2023 | S |
| Drug use screening with the DAST-10; naloxone and overdose education if any opioid use is reported or suspected | completed | GL-USPSTF-DRUG-2020, GL-SAMHSA-NALOXONE | S |
| Start a single-pill combination of amlodipine 5 mg and valsartan 160 mg each morning for stage 2 hypertension; potassium and creatinine in two to four weeks; home blood pressure with a talking, large-display monitor; lower-salt eating and alcohol reduction | completed | GL-AHA-HTN-2025, GL-CMID-2026 | S |
| Competing: no bouts until blood pressure is controlled, then clearance by the commission physician with a repeat check; no stimulants, decongestants or weight-cut diuretics | completed | GL-ATHLETE-HTN-2015 | S |
| Raise the combination to amlodipine 10 mg and valsartan 160 mg; start naltrexone 50 mg each morning, with a wallet card saying it blocks opioid pain medicines and a liver test recheck in two months | completed | GL-AHA-HTN-2025, GL-APA-AUD-2018, GL-SUD-2021 | S |
| Cardiovascular risk and preventive care at the preventive visit: lipids, risk estimate, immunizations and one-time screenings | completed | GL-CMID-2026, GL-AHA-HTN-2025 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Confirm or rule out hypertension with out-of-office readings before any medicine | 1969-06-23 | completed | Ambulatory monitoring confirmed stage 2 hypertension (daytime 146/94 mmHg) | S |
| Blood pressure under 130/80 mmHg in the clinic and at home by four months | 1969-10-20 | completed | Clinic 122/76 mmHg; home average 120/76 mmHg on amlodipine 10 mg and valsartan 160 mg | S |
| Drink within the goal he set: no more than 14 drinks a week and no more than 4 on any day, and none in the two weeks before a fight | 1969-10-20 | completed | About 8 drinks a week with no day above 3; AUDIT 7; GGT normal | S |
| Explain his medicines and blood pressure plan back in his own words | 1969-07-21 | completed | Teach-back correct at four weeks with the picture card | S |
Structured synthetic safety assessment on 1969-06-09: current ideation absent, intent absent, plan absent. Outpatient care with a spoken and picture-based safety plan, the 988 Suicide & Crisis Lifeline saved in his phone by voice contact, and a two-week follow-up; safety reviewed at every visit [S]